"With the outbreak of COVID-19, we want to ensure we are ready to care for the most critically ill patients while also meeting your needs. New or previously scheduled appointments may be changed to a video or phone visit so you can stay home and still receive quality care. Most prescriptions can be ordered via mail. Visit our website to schedule a virtual appointment, request mail order for your prescription or send an email to your doctor’s office. Our doctors are postponing elective or non-urgent surgeries and procedures."

During the past decade, Kaiser Permanente - Fair Oaks Medical Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 9 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kaiser Permanente - Fair Oaks Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 4 trials, followed by "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "NSABP Foundation Inc" with 3 trials sponsored, "ETOP IBCSG Partners Foundation" with 1 trials sponsored and "Eastern Cooperative Oncology Group" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kaiser Permanente - Fair Oaks Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 9 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator, "SWOG Cancer Research Network" with 2 trials as a collaborator and "Breast International Group" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Kaiser Permanente - Fair Oaks Medical Center" are "Recurrent Breast Carcinoma" (3 trials), "Breast Cancer" (2 trials), "Breast Adenocarcinoma" (1 trials), "Breast Ductal Carcinoma In Situ" (1 trials) and "Colorectal Cancer" (1 trials). Many other conditions were trialed in "Kaiser Permanente - Fair Oaks Medical Center" in a lesser frequency.

Most popular intervention types in "Kaiser Permanente - Fair Oaks Medical Center" are "Drug" (10 trials), "Other" (9 trials), "Biological" (6 trials), "Procedure" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (6 trials), "Paclitaxel" (4 trials), "Quality-of-Life Assessment" (4 trials), "Bevacizumab" (2 trials) and "Carboplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Kaiser Permanente - Fair Oaks Medical Center" are 9 trials for "Female" genders, 3 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Kaiser Permanente - Fair Oaks Medical Center". undefined are not yet recruiting, undefined are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Kaiser Permanente - Fair Oaks Medical Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Kaiser Permanente - Fair Oaks Medical Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".